Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Allergan's patent for latisse expired?How much is mebendazole?Patent expiry trametinib?Can grapefruit juice decrease lipitor's benefits?Dabrafenib and trametinib price?
Artesunate, an antimalarial from the artemisinin class, is contraindicated in patients with known hypersensitivity to artesunate itself or any artemisinin derivatives (e.g., artemether, arteether). This includes immediate allergic reactions like anaphylaxis, urticaria, or severe rash.[1][2]
Hypersensitivity manifests as skin reactions (itching, hives), respiratory distress, swelling, or shock. Cross-reactivity occurs within the artemisinin family due to shared chemical structures, so allergy to one typically rules out others.[2][3]
Skin testing or graded challenge dosing may confirm allergy before use. Desensitization protocols exist for confirmed cases in life-threatening malaria.[3][5] Always check product labels—IV forms carry higher sulfite risks than oral.
Artemisinin allergies affect <1% of users, but in severe malaria, untreated allergy risks outweigh benefits only if alternatives like quinine are viable.[2][6] [1]: FDA Label - Artesunate (IV) [2]: WHO Guidelines on Antimalarials [3]: Journal of Allergy and Clinical Immunology - Artemisinin Hypersensitivity [4]: Drugs.com - Artesunate Prescribing Info [5]: Clinical Infectious Diseases - Desensitization Case Reports [6]: CDC Malaria Treatment
Other Questions About Allergies :